Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

NCT01261325 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

768

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Placebo
DRUG: Brivaracetam
DRUG: Brivaracetam
DRUG: Antiepileptic drugs with market authorization available per country

Sponsor

UCB Pharma